Literature DB >> 11003735

Lack of hepatitis E infection among backpackers to tropical countries.

I Potasman1, L Koren, M Peterman, I Srugo.   

Abstract

Hepatitis E virus (HEV) is a feco-orally transmitted virus that occurs primarily among the indigenous populations of the Indian subcontinent, Central America and Africa. Most recognized cases of HEV occur after contamination of water supplies such as after monsoon flooding.1,2 In contrast with hepatitis A infection, secondary person-to-person spread is rare. Most cases of HEV are reported in epidemics, but sporadic cases also occur. Backpackers traveling from developed to developing countries are potentially at increased risk for acquisition of feco-orally transmitted organisms. The risk of acquisition of HEV among backpackers is unclear. We aimed at studying prospectively the rate of HEV in a group of backpackers and its association with lifestyle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003735     DOI: 10.2310/7060.2000.00062

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  4 in total

1.  Seroprevalence of Hepatitis E Among Boston Area Travelers, 2009-2010.

Authors:  Kira A Barbre; Emily S Jentes; Jan Drobeniuc; Saleem Kamili; Davidson H Hamer; Elizabeth D Barnett
Journal:  Am J Trop Med Hyg       Date:  2017-01-30       Impact factor: 2.345

2.  Hepatitis a and e infection in international travellers.

Authors:  Joseph Torresi; Douglas Johnson
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 3.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

4.  Hepatitis E in Long-Term Travelers from the Netherlands to Subtropical and Tropical Countries, 2008-2011.

Authors:  Floortje Elfrink; Femke W Overbosch; Janke Schinkel; Gerrit Koen; Gerard J B Sonder
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.